Posterior maximization and averaging for Bayesian working model choice in the continual reassessment method
暂无分享,去创建一个
J O'Quigley | T Daimon | S Zohar | J. O'Quigley | S. Zohar | T. Daimon | Sarah Zohar | John O'Quigley | Takashi Daimon
[1] B E Storer,et al. Design and analysis of phase I clinical trials. , 1989, Biometrics.
[2] Alexia Iasonos,et al. A Comprehensive Comparison of the Continual Reassessment Method to the Standard 3 + 3 Dose Escalation Scheme in Phase I Dose-Finding Studies , 2008, Clinical trials.
[3] J O'Quigley,et al. Continual reassessment method: a likelihood approach. , 1996, Biometrics.
[4] S Zacks,et al. Cancer phase I clinical trials: efficient dose escalation with overdose control. , 1998, Statistics in medicine.
[5] John O'Quigley,et al. Consistency of continual reassessment method under model misspecification , 1996 .
[6] Anastasia Ivanova,et al. Improved up‐and‐down designs for phase I trials , 2003, Statistics in medicine.
[7] Ying Kuen Cheung,et al. A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method , 2002, Biometrics.
[8] Ying Yuan,et al. Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials , 2009 .
[9] Ying Kuen Cheung,et al. Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose , 2007 .
[10] J O'Quigley,et al. Another look at two phase I clinical trial designs. , 1999, Statistics in medicine.
[11] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[12] W J Shih,et al. Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials. , 2001, Biostatistics.
[13] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[14] Anastasia Ivanova,et al. Escalation, group and A + B designs for dose‐finding trials , 2006, Statistics in medicine.
[15] Shing M. Lee,et al. Model calibration in the continual reassessment method , 2009, Clinical trials.
[16] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[17] J Whitehead,et al. Bayesian decision procedures based on logistic regression models for dose-finding studies. , 1998, Journal of biopharmaceutical statistics.
[18] Alan E. Gelfand,et al. Model choice: A minimum posterior predictive loss approach , 1998, AISTATS.
[19] Sarah Zohar,et al. Retrospective Robustness of the Continual Reassessment Method , 2010, Journal of biopharmaceutical statistics.